Is IDEXX Laboratories, Inc. (IDXX) Stock a Sell after Jonathan Ayers’s Insider Sale?; KOMAX HOLDING AG DIERIKON NAMEN (KMAAF) Sellers Increased By 24.69% Their Shorts

The Chairman – President & CEO of Idexx Laboratories Inc De, Jonathan Ayers has made an unexpected deal in the Maine-based Idexx Laboratories Inc De that is having a total value $3,905,383 U.S. Dollars. As stated in the D.C. based-SEC public document filed on February 09, 2018, Jonathan unloaded 22,000 shares at an average price-per-share of $177.5. This is not his first insider trade, in the last 30 days, he unloaded another 90,000 shares worth $15,416,747 USD. Due to the significance of this trade, it will not go undiscovered. Jonathan Ayers owns 1.33% of the -company’s market cap with a total of 1.16 million shares.

KOMAX HOLDING AG DIERIKON NAMEN (OTCMKTS:KMAAF) had an increase of 24.69% in short interest. KMAAF’s SI was 10,100 shares in February as released by FINRA. Its up 24.69% from 8,100 shares previously. With 100 avg volume, 101 days are for KOMAX HOLDING AG DIERIKON NAMEN (OTCMKTS:KMAAF)’s short sellers to cover KMAAF’s short positions. It closed at $308 lastly. It is down 0.00% since February 10, 2017 and is . It has underperformed by 16.70% the S&P500.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company has market cap of $15.08 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions. It has a 58.83 P/E ratio. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

Since August 14, 2017, it had 0 insider purchases, and 5 sales for $19.36 million activity. MCKEON BRIAN P sold $1.20M worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) on Monday, February 5. The insider AYERS JONATHAN W sold 36,000 shares worth $6.45 million. HENDERSON REBECCA M had sold 5,156 shares worth $790,342.

Among 11 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 7 have Buy rating, 2 Sell and 2 Hold. Therefore 64% are positive. IDEXX Laboratories has $220 highest and $69.50 lowest target. $166.06’s average target is -3.98% below currents $172.95 stock price. IDEXX Laboratories had 27 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Thursday, February 4 by Credit Suisse. The stock has “Buy” rating by Stifel Nicolaus on Monday, August 21. The firm has “Buy” rating given on Friday, July 28 by C.L. King. The rating was reinitiated by Bank of America with “Neutral” on Thursday, September 29. The stock has “Buy” rating by Bank of America on Wednesday, August 23. The firm has “Market Perform” rating by Raymond James given on Friday, August 28. The firm has “Buy” rating by Canaccord Genuity given on Thursday, October 5. The rating was maintained by Credit Suisse with “Outperform” on Wednesday, April 13. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Buy” rating given on Monday, March 21 by Stifel Nicolaus. On Thursday, October 29 the stock rating was maintained by Stifel Nicolaus with “Buy”.

The stock increased 2.17% or $3.67 during the last trading session, reaching $172.95. About 726,185 shares traded or 34.77% up from the average. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 83.30% since February 10, 2017 and is uptrending. It has outperformed by 66.60% the S&P500.

Investors sentiment decreased to 0.86 in 2017 Q3. Its down 0.33, from 1.19 in 2017Q2. It dived, as 39 investors sold IDEXX Laboratories, Inc. shares while 196 reduced holdings. 55 funds opened positions while 146 raised stakes. 87.85 million shares or 15.07% more from 76.34 million shares in 2017Q2 were reported. Magnetar Fincl Ltd Liability has 1,861 shares. Swiss Retail Bank invested in 324,500 shares or 0.06% of the stock. First Quadrant Lp Ca owns 205,048 shares for 0.62% of their portfolio. Strs Ohio invested in 6,184 shares. Parsons Capital Mgmt Ri invested in 0.04% or 2,000 shares. Stifel reported 0.01% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Df Dent Co owns 122,429 shares for 0.49% of their portfolio. 24,187 were reported by Texas Permanent School Fund. Legal & General Gru Public Limited holds 0.05% or 434,703 shares in its portfolio. Vanguard Gru stated it has 0.07% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Teacher Retirement Systems Of Texas holds 23,141 shares or 0.02% of its portfolio. Sandhill Cap Prns Llc owns 2.66% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 87,792 shares. Boothbay Fund Ltd accumulated 0.05% or 1,802 shares. 420,486 were accumulated by Atlantic Trust Gp Limited Liability Company. Federated Invsts Pa holds 688,442 shares or 0.31% of its portfolio.